Literature DB >> 24614973

PACAP enhances barrier properties of cerebral microvessels.

Imola Wilhelm1, Csilla Fazakas, Andrea Tamás, Gábor Tóth, Dóra Reglődi, István A Krizbai.   

Abstract

Cerebral microvascular endothelial cells-coming in contact with pericytes and astrocytes-constitute the structural basis of the blood-brain barrier (BBB). The continuous belt of interendothelial tight junctions (TJs) and the presence of specific transport systems, enzymes, and receptors in the brain endothelium regulate the molecular and cellular traffic into the central nervous system. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide having several cellular protective effects. However, little is known about the effects of PACAP on the cerebral endothelium and BBB functions. Here, we show that PACAP has no significant pro-survival role in cerebral microvascular endothelial cells; however, it improves the barrier properties of the brain endothelium. PACAP induces an increase in the transendothelial electrical resistance, which is the most important marker of the tightness of the TJs. Moreover, PACAP has a protective role against glucose deprivation- and oxidative stress-induced junctional damage in microvascular brain endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24614973     DOI: 10.1007/s12031-014-0260-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  32 in total

Review 1.  The cell biology of the blood-brain barrier.

Authors:  L L Rubin; J M Staddon
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

2.  Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats.

Authors:  Salvatore Giunta; Alessandro Castorina; Claudio Bucolo; Gaetano Magro; Filippo Drago; Velia D'Agata
Journal:  Peptides       Date:  2012-06-18       Impact factor: 3.750

3.  Quinidine as an ABCB1 probe for testing drug interactions at the blood-brain barrier: an in vitro in vivo correlation study.

Authors:  István Sziráki; Franciska Erdo; Erzsébet Beéry; Petra Magdolna Molnár; Csilla Fazakas; Imola Wilhelm; Ildikó Makai; Emese Kis; Krisztina Herédi-Szabó; Tibor Abonyi; István Krizbai; Gábor K Tóth; Péter Krajcsi
Journal:  J Biomol Screen       Date:  2011-08-10

Review 4.  In vitro models of the blood-brain barrier.

Authors:  Imola Wilhelm; Csilla Fazakas; Istvan A Krizbai
Journal:  Acta Neurobiol Exp (Wars)       Date:  2011       Impact factor: 1.579

5.  Adrenomedullin regulates blood-brain barrier functions in vitro.

Authors:  B Kis; M A Deli; H Kobayashi; C S Abrahám; T Yanagita; H Kaiya; T Isse; R Nishi; S Gotoh; K Kangawa; A Wada; J Greenwood; M Niwa; H Yamashita; Y Ueta
Journal:  Neuroreport       Date:  2001-12-21       Impact factor: 1.837

6.  Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury.

Authors:  D M Jaworski
Journal:  Cell Tissue Res       Date:  2000-05       Impact factor: 5.249

7.  Pituitary adenylate cyclase-activating polypeptide induces pial arteriolar vasodilation through cyclooxygenase-dependent and independent mechanisms in newborn pigs.

Authors:  Laura Lenti; Ferenc Domoki; David Kis; Orsolya Hegyi; Gabor K Toth; David W Busija; Ferenc Bari
Journal:  Brain Res       Date:  2007-06-27       Impact factor: 3.252

8.  Age-related decrease in cerebrovascular-derived neuroprotective proteins: effect of acetaminophen.

Authors:  Debjani Tripathy; Alma Sanchez; Xiangling Yin; Joseph Martinez; Paula Grammas
Journal:  Microvasc Res       Date:  2012-08-27       Impact factor: 3.514

9.  Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier.

Authors:  W A Banks; A J Kastin; G Komaki; A Arimura
Journal:  J Pharmacol Exp Ther       Date:  1993-11       Impact factor: 4.030

10.  Wnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitro.

Authors:  Roberta Paolinelli; Monica Corada; Luca Ferrarini; Kavi Devraj; Cédric Artus; Cathrin J Czupalla; Noemi Rudini; Luigi Maddaluno; Eleanna Papa; Britta Engelhardt; Pierre Olivier Couraud; Stefan Liebner; Elisabetta Dejana
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more
  7 in total

Review 1.  Dissecting the Contribution of Vascular Alterations and Aging to Alzheimer's Disease.

Authors:  Cátia Janota; Cynthia A Lemere; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2015-07-05       Impact factor: 5.590

2.  Age-related decline of autocrine pituitary adenylate cyclase-activating polypeptide impairs angiogenic capacity of rat cerebromicrovascular endothelial cells.

Authors:  Eszter Banki; Danuta Sosnowska; Zsuzsanna Tucsek; Tripti Gautam; Peter Toth; Stefano Tarantini; Andrea Tamas; Zsuzsanna Helyes; Dora Reglodi; William E Sonntag; Anna Csiszar; Zoltan Ungvari
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-08-18       Impact factor: 6.053

3.  Early Neurobehavioral Development of Mice Lacking Endogenous PACAP.

Authors:  Jozsef Farkas; Balazs Sandor; Andrea Tamas; Peter Kiss; Hitoshi Hashimoto; Andras D Nagy; Balazs D Fulop; Tamas Juhasz; Sridharan Manavalan; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2017-02-06       Impact factor: 3.444

Review 4.  Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death.

Authors:  Gabriella Horvath; Dora Reglodi; Eszter Fabian; Balazs Opper
Journal:  Int J Mol Sci       Date:  2022-04-29       Impact factor: 6.208

5.  Characterization of the thermoregulatory response to pituitary adenylate cyclase-activating polypeptide in rodents.

Authors:  Eszter Banki; Eszter Pakai; Balazs Gaszner; Csaba Zsiboras; Andras Czett; Paras Rahul Parkash Bhuddi; Hitoshi Hashimoto; Gabor Toth; Andrea Tamas; Dora Reglodi; Andras Garami
Journal:  J Mol Neurosci       Date:  2014-07-04       Impact factor: 3.444

6.  Pituitary Adenylate Cyclase-Activating Polypeptide Attenuates Brain Edema by Protecting Blood-Brain Barrier and Glymphatic System After Subarachnoid Hemorrhage in Rats.

Authors:  Yuanjian Fang; Hui Shi; Reng Ren; Lei Huang; Takeshi Okada; Cameron Lenahan; Marcin Gamdzyk; Zachary D Travis; Qin Lu; Lihui Tang; Yi Huang; Keren Zhou; Jiping Tang; Jianmin Zhang; John H Zhang
Journal:  Neurotherapeutics       Date:  2020-09-11       Impact factor: 7.620

Review 7.  Pituitary Adenylate Cyclase-Activating Polypeptide: A Promising Neuroprotective Peptide in Stroke.

Authors:  Yuanjian Fang; Reng Ren; Hui Shi; Lei Huang; Cameron Lenahan; Qin Lu; Lihui Tang; Yi Huang; Jiping Tang; Jianmin Zhang; John H Zhang
Journal:  Aging Dis       Date:  2020-12-01       Impact factor: 6.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.